Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15348663 | 1.00 | LMNA (0.35) | LMNA | |
| SCHEMBL7158122 | 1.00 | LMNA (0.35) | LMNA | |
| SCHEMBL7157048 | 1.00 | LMNA (0.35) | LMNA | |
| SCHEMBL1800341 | 1.00 | LMNA (0.35) | LMNA | |
| SCHEMBL7164000 | 1.00 | LMNA (0.35) | LMNA | |
| SCHEMBL7165980 | 1.00 | LMNA (0.35) | LMNA | |
| SCHEMBL2184710 | 0.97 | LMNA (0.30) | LMNA | |
| SCHEMBL4388546 | 0.88 | — | — | |
| SCHEMBL8653865 | 0.81 | — | — | |
| SCHEMBL7160736 | 0.79 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492318-B2 | Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same | ETNA-TEC, LTD. (US) | 2022-11-08 | — | — | US | disclosed |
| US-20220213016-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ETNA-TEC, LTD. | 2022-07-07 | — | — | US | disclosed |
| US-20180334417-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ETNA-TEC, LTD. | 2018-11-22 | — | — | US | disclosed |
| EP-2623335-B1 | Surface modification method and surface-modified elastic body | SUMITOMO RUBBER IND (JP) | 2018-03-14 | — | — | EP | disclosed |
| US-9321872-B2 | Surface modification method and surface-modified elastic body | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2016-04-26 | — | — | US | disclosed |
| US-9044922-B2 | Self-releasing fuser members and methods of making the same | XEROX CORPORATION (US) | 2015-06-02 | — | — | US | disclosed |
| US-20130288059-A1 | SELF-RELEASING FUSER MEMBERS AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130203883-A1 | SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2013-08-08 | — | — | US | disclosed |
| US-6552161-B1 | Fluorinated diamine; it's polyamic acid and polyimide with at least one tetracarboxylic dianhydride | ELSICON, INC. | 2003-04-22 | — | — | US | disclosed |
| US-6451960-B1 | POLYAMIC ACIDS PREPARED FROM POLARIZABLE FLUORINATED AMINES AND AT LEAST ONE TETRACARBOXYLIC DIANHYDRIDE AND THE CORRESPONDING POLYIMIDES DERIVED THEREFROM | ELSICON, INC. | 2002-09-17 | — | — | US | disclosed |
| US-6084057-A | POLYAMIC ACID WHERE THE AMINE COMPONENT IS A POLARIZABLE DIAMINE HAVING A FLUOROCARBON MOIETY AND POLAR GROUP COMPRISING A PI ELECTRON SYSTEM CONTAINING AT LEAST ONE HETEROATOM; POLYIMIDE THEREFROM | ELSICON, INC. (US) | 2000-07-04 | — | — | US | disclosed |
| US-6043337-A | FIR LIQUID CRYSTAL DISPLAY ELEMENTS | ELSICON, INC. (US) | 2000-03-28 | — | — | US | disclosed |
| US-5929201-A | A POLYAMIC ACID IS THE REACTION PRODUCT OF A FLUORINATED MONOAMINE, A DIAMINE AND ATLEAST ONE TETERACARBOXYLIC DIANHYDRIDE | ELSICON, INC. (US) | 1999-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180334417-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ALKBH3, FTO, THEM6 | LMNA 1217/4885 |
| US-20220213016-A1 | Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same | ALKBH3, FTO, ALK | LMNA 1234/4885 |
| US-11492318-B2 | Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same | ALKBH3, FTO, ALK | LMNA 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.